EXACT Sciences reported a GAAP loss of $180.937 million for the first three months of 2022, up 5.8 times from $31.164 million in the previous year. Revenue increased 21% to $486.571 million from $402.077 million a year earlier.
EXACT Sciences reported a GAAP loss of $180.937 million for the first three months of 2022, up 5.8 times from $31.164 million in the previous year. Revenue increased 21% to $486.571 million from $402.077 million a year earlier. 
investor.exactsciences.com
English (US) 